Nations Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.71M | Sell |
71,165
-19,424
| -21% | -$508K | 0.08% | 253 |
|
|
2026
Q1 | $2.54M | Sell |
90,589
-2,449
| -3% | -$65.2K | 0.13% | 185 |
|
|
2025
Q4 | $2.32M | Buy |
93,038
+3,573
| +4% | +$90.1K | 0.12% | 189 |
|
|
2025
Q3 | $2.28M | Buy |
89,465
+2,328
| +3% | +$57.5K | 0.14% | 175 |
|
|
2025
Q2 | $2.11M | Sell |
87,137
-55,157
| -39% | -$1.29M | 0.15% | 172 |
|
|
2025
Q1 | $3.61M | Buy |
142,294
+1,245
| +0.9% | +$32.6K | 0.28% | 86 |
|
|
2024
Q4 | $3.74M | Buy |
141,049
+55,294
| +64% | +$1.5M | 0.27% | 93 |
|
|
2024
Q3 | $2.48M | Buy |
85,755
+5,128
| +6% | +$150K | 0.18% | 136 |
|
|
2024
Q2 | $2.26M | Buy |
80,627
+34,670
| +75% | +$955K | 0.18% | 132 |
|
|
2024
Q1 | $1.28M | Sell |
45,957
-7,626
| -14% | -$212K | 0.11% | 216 |
|
|
2023
Q4 | $1.54M | Buy |
53,583
+1,749
| +3% | +$52.9K | 0.14% | 166 |
|
|
2023
Q3 | $1.72M | Sell |
51,834
-8,378
| -14% | -$296K | 0.17% | 143 |
|
|
2023
Q2 | $2.21M | Sell |
60,212
-32,883
| -35% | -$1.28M | 0.22% | 111 |
|
|
2023
Q1 | $3.8M | Sell |
93,095
-5,204
| -5% | -$225K | 0.4% | 50 |
|
|
2022
Q4 | $5.04M | Buy |
98,299
+1,828
| +2% | +$87.6K | 0.57% | 29 |
|
|
2022
Q3 | $4.22M | Buy |
96,471
+15,888
| +20% | +$772K | 0.61% | 29 |
|
|
2022
Q2 | $4.22M | Buy |
80,583
+4,106
| +5% | +$209K | 0.57% | 32 |
|
|
2022
Q1 | $3.96M | Buy |
76,477
+17,910
| +31% | +$929K | 0.48% | 43 |
|
|
2021
Q4 | $3.46M | Buy |
58,567
+24,920
| +74% | +$1.23M | 0.46% | 44 |
|
|
2021
Q3 | $1.45M | Buy |
33,647
+304
| +0.9% | +$13.5K | 0.22% | 117 |
|
|
2021
Q2 | $1.31M | Sell |
33,343
-697
| -2% | -$27.1K | 0.22% | 117 |
|
|
2021
Q1 | $1.23M | Buy |
34,040
+131
| +0.4% | +$4.65K | 0.28% | 99 |
|
|
2020
Q4 | $1.25M | Sell |
33,909
-1,552
| -4% | -$56.9K | 0.33% | 82 |
|
|
2020
Q3 | $1.24M | Buy |
35,461
+2,298
| +7% | +$80.6K | 0.38% | 68 |
|
|
2020
Q2 | $1.03M | Buy |
33,163
+4,364
| +15% | +$148K | 0.37% | 77 |
|
|
2020
Q1 | $892K | Sell |
28,799
-466
| -2% | -$15.9K | 0.38% | 72 |
|
|
2019
Q4 | $1.09M | Buy |
29,265
+15
| +0.1% | +$534 | 0.38% | 75 |
|
|
2019
Q3 | $1.06M | Buy |
29,250
+768
| +3% | +$27.9K | 0.38% | 71 |
|
|
2019
Q2 | $1.17M | Sell |
28,482
-1,560
| -5% | -$61.9K | 0.77% | 25 |
|
|
2019
Q1 | $1.21M | Sell |
30,042
-583
| -2% | -$23.3K | 0.83% | 23 |
|
|
2018
Q4 | $1.27M | Buy |
30,625
+1,144
| +4% | +$47.5K | 1.02% | 19 |
|
|
2018
Q3 | $1.23M | Buy |
29,481
+3,626
| +14% | +$140K | 0.88% | 22 |
|
|
2018
Q2 | $890K | Sell |
25,855
-1,146
| -4% | -$39.2K | 0.74% | 27 |
|
|
2018
Q1 | $909K | Buy |
27,001
+437
| +2% | +$15K | 0.83% | 25 |
|
|
2017
Q4 | $913K | Sell |
26,564
-572
| -2% | -$19.5K | 0.84% | 25 |
|
|
2017
Q3 | $919K | Sell |
27,136
-1,216
| -4% | -$39.1K | 0.89% | 25 |
|
|
2017
Q2 | $904K | Sell |
28,352
-1,244
| -4% | -$39.2K | 0.74% | 37 |
|
|
2017
Q1 | $961K | Buy |
29,596
+2,945
| +11% | +$92.9K | 0.94% | 30 |
|
|
2016
Q4 | $821K | Sell |
26,651
-87
| -0.3% | -$2.66K | 0.89% | 35 |
|
|
2016
Q3 | $859K | Buy |
26,738
+325
| +1% | +$10.9K | 0.85% | 36 |
|
|
2016
Q2 | $882K | Buy |
26,413
+247
| +0.9% | +$7.88K | 0.92% | 28 |
|
|
2016
Q1 | $736K | Sell |
26,166
-468
| -2% | -$13.4K | 0.85% | 35 |
|
|
2015
Q4 | $816K | Buy |
+26,634
| New | +$838K | 1.06% | 27 |
|
Other funds holding PFE
Nations Financial Group's PFE Position: Q2 2026 in Review
Nations Financial Group reduced its Pfizer (PFE) stake by 21% in Q2 2026, selling an estimated $508K and leaving 71,165 shares worth $1.71M. The position accounts for 0.08% of the portfolio, ranked #253.
Nations Financial Group first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $5.04M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Nations Financial Group held 71,165 shares of Pfizer worth $1.71M as of Q2 2026.
- Nations Financial Group sold 19,424 Pfizer shares in Q2 2026, an estimated $508K.
- Pfizer made up 0.08% of Nations Financial Group's portfolio in Q2 2026, its #253 holding.
- Nations Financial Group first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
- Nations Financial Group's Pfizer position peaked at $5.04M in Q4 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.